Cell Culture-Derived Tilapia Lake Virus-Inactivated Vaccine Containing Montanide Adjuvant Provides High Protection against Viral Challenge for Tilapia

Tilapia lake virus (TiLV) is a newly emerging pathogen responsible for high mortality and economic losses in the global tilapia industry. Currently, no antiviral therapy or vaccines are available for the control of this disease. The goal of the present study was to evaluate the immunological effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Weiwei, Wang, Yingying, Hu, Huzi, Wang, Qing, Bergmann, Sven M., Wang, Yahui, Li, Bo, Lv, Yuefeng, Li, Hua, Yin, Jiyuan, Li, Yingying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911875/
https://www.ncbi.nlm.nih.gov/pubmed/33503930
http://dx.doi.org/10.3390/vaccines9020086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911875/
https://www.ncbi.nlm.nih.gov/pubmed/33503930
http://dx.doi.org/10.3390/vaccines9020086

Ejemplares similares